Materialise’s TRUMATCH® lights up the US market

Materialise NV has announced that U.S. patients can now benefit from their patient-specific implants, 3D-printed in titanium for maxillofacial surgery. As the first 3D-printed titanium maxillofacial implants to receive clearance for the U.S. market, the decision marks a further extension to Materialise’s longstanding collaboration with DePuy Synthes, who will distribute the device in the U.S.

The TRUMATCH® titanium 3D-printed implants are part of a personalized total solution for orthognathic surgery, also known as corrective jaw surgery, as well as for facial reconstruction. It has achieved positive results in European and Australian markets since its introduction in 2016.

These are the first 3D-printed titanium maxillofacial implants to receive clearance for the U.S. market, making 3D printing technology more accessible than ever for the U.S. healthcare industry. The solution relies on the Materialise backbone of services, tapping into their software development, clinical engineering and 3D printing production facilities.